Key result
Potassium supplementation lowers BP and reduces risk of CVD, HF, CKD, stroke, and death.
Why the study?
Potassium has antihypertensive and cardioprotective effects, but its supplementation is infrequent, worldwide intake is low, and it is not frequently recommended by scientific societies.
Does potassium supplementation reduce blood pressure and cardiovascular events in hypertensive patients?
Does potassium supplementation reduce blood pressure and cardiovascular events in hypertensive patients?
Potassium supplementation is an effective and accessible strategy to lower blood pressure and reduce cardiovascular risk, despite being underutilized and under-recommended by current guidelines.
This study aims to present the current evidence on the antihypertensive and cardioprotective properties of potassium. Increased potassium intake has been associated with antihypertensive and cardioprotective effects demonstrated by many studies, but its supplementation is infrequent in many countries and not frequently recommended by scientific societies. Hypertension is very common and a major risk factor for cardiovascular disease, heart failure, chronic kidney disease, strokes, and death, but it is poorly controlled, especially in developing countries. The causes for this are multiple and one of them could be the low potassium supplementation or lack of it. A review of the literature revealed that potassium supplementation decreases blood pressure, cardiovascular disease, heart failure, chronic kidney disease, strokes, and death. However, its intake is low and not recommended by several societal blood pressure treatment guidelines with the worldwide potassium intake to be quite low. This is happening despite the fact that potassium supplementation is very easy through potassium salt supplements and from the intake of fruits and vegetables rich in potassium content. Therefore, potassium intake should be recommended by physicians to their hypertensive patients, since its benefits significantly outweigh its risks.
No takes yet. Share an insight, caveat, or question.
Steven G. Chrysant (2025) conducted a review in Hypertension and cardiovascular disease. Potassium supplementation was evaluated on Blood pressure, cardiovascular disease, heart failure, chronic kidney disease, strokes, and death. Potassium supplementation decreases blood pressure and the risk of cardiovascular disease, heart failure, chronic kidney disease, strokes, and death, though its intake remains low worldwide.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: